139 related articles for article (PubMed ID: 21589650)
1. Application of hydroxyapatite nanoparticles in development of an enhanced formulation for delivering sustained release of triamcinolone acetonide.
Koocheki S; Madaeni SS; Niroomandi P
Int J Nanomedicine; 2011; 6():825-33. PubMed ID: 21589650
[TBL] [Abstract][Full Text] [Related]
2. Depot injectable atorvastatin biodegradable in situ gel: development, optimization, in vitro, and in vivo evaluation.
Ahmed TA; Alharby YA; El-Helw AR; Hosny KM; El-Say KM
Drug Des Devel Ther; 2016; 10():405-15. PubMed ID: 26855565
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic analysis of triamcinolone acetonide release from PLGA microspheres as a function of varying in vitro release conditions.
Doty AC; Zhang Y; Weinstein DG; Wang Y; Choi S; Qu W; Mittal S; Schwendeman SP
Eur J Pharm Biopharm; 2017 Apr; 113():24-33. PubMed ID: 27865933
[TBL] [Abstract][Full Text] [Related]
4. Design and Development of Bioceramic Based Functionalized PLGA Nanoparticles of Risedronate for Bone Targeting: In-vitro Characterization and Pharmacodynamic Evaluation.
Rawat P; Manglani K; Gupta S; Kalam A; Vohora D; Ahmad FJ; Talegaonkar S
Pharm Res; 2015 Oct; 32(10):3149-58. PubMed ID: 25840949
[TBL] [Abstract][Full Text] [Related]
5. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.
Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP
Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221
[TBL] [Abstract][Full Text] [Related]
6. Nimodipine loaded PLGA nanoparticles: formulation optimization using factorial design, characterization and in vitro evaluation.
Mehta AK; Yadav KS; Sawant KK
Curr Drug Deliv; 2007 Jul; 4(3):185-93. PubMed ID: 17627492
[TBL] [Abstract][Full Text] [Related]
7. Controlled release of amoxicillin from hydroxyapatite-coated poly(lactic-co-glycolic acid) microspheres.
Xu Q; Czernuszka JT
J Control Release; 2008 Apr; 127(2):146-53. PubMed ID: 18325617
[TBL] [Abstract][Full Text] [Related]
8. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
Xu H; Zhong H; Liu M; Xu C; Gao Y
Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119
[TBL] [Abstract][Full Text] [Related]
9. Selective anticancer activity of hydroxyapatite/chitosan-poly(d,l)-lactide-co-glycolide particles loaded with an androstane-based cancer inhibitor.
Ignjatović NL; Penov-Gaši KM; Wu VM; Ajduković JJ; Kojić VV; Vasiljević-Radović D; Kuzmanović M; Uskoković V; Uskoković DP
Colloids Surf B Biointerfaces; 2016 Dec; 148():629-639. PubMed ID: 27694053
[TBL] [Abstract][Full Text] [Related]
10. Development of meloxicam in situ implant formulation by quality by design principle.
Ibrahim HM; Ahmed TA; Hussain MD; Rahman Z; Samy AM; Kaseem AA; Nutan MT
Drug Dev Ind Pharm; 2014 Jan; 40(1):66-73. PubMed ID: 23298324
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of in vivo release of triamcinolone acetonide from PLGA microspheres.
Doty AC; Weinstein DG; Hirota K; Olsen KF; Ackermann R; Wang Y; Choi S; Schwendeman SP
J Control Release; 2017 Jun; 256():19-25. PubMed ID: 28342981
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir.
Yang X; Shah SJ; Wang Z; Agrahari V; Pal D; Mitra AK
Drug Deliv; 2016 Sep; 23(7):2399-2409. PubMed ID: 25564964
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
[TBL] [Abstract][Full Text] [Related]
14. Low temperature formation of calcium-deficient hydroxyapatite-PLA/PLGA composites.
Durucan C; Brown PW
J Biomed Mater Res; 2000 Sep; 51(4):717-25. PubMed ID: 10880121
[TBL] [Abstract][Full Text] [Related]
15. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats.
Li Y; Pei Y; Zhang X; Gu Z; Zhou Z; Yuan W; Zhou J; Zhu J; Gao X
J Control Release; 2001 Apr; 71(2):203-11. PubMed ID: 11274752
[TBL] [Abstract][Full Text] [Related]
16. Application of electrospraying as a one-step method for the fabrication of triamcinolone acetonide-PLGA nanofibers and nanobeads.
Jahangiri A; Davaran S; Fayyazi B; Tanhaei A; Payab S; Adibkia K
Colloids Surf B Biointerfaces; 2014 Nov; 123():219-24. PubMed ID: 25260224
[TBL] [Abstract][Full Text] [Related]
17. A potential in situ gel formulation loaded with novel fabricated poly(lactide-co-glycolide) nanoparticles for enhancing and sustaining the ophthalmic delivery of ketoconazole.
Ahmed TA; Aljaeid BM
Int J Nanomedicine; 2017; 12():1863-1875. PubMed ID: 28331311
[TBL] [Abstract][Full Text] [Related]
18. Flow-through cell-based in vitro release method for triamcinolone acetonide poly (lactic-co-glycolic) acid microspheres.
Tipnis NP; Shen J; Jackson D; Leblanc D; Burgess DJ
Int J Pharm; 2020 Apr; 579():119130. PubMed ID: 32070759
[TBL] [Abstract][Full Text] [Related]
19. Preparation of DHAQ-loaded mPEG-PLGA-mPEG nanoparticles and evaluation of drug release behaviors in vitro/in vivo.
Duan Y; Sun X; Gong T; Wang Q; Zhang Z
J Mater Sci Mater Med; 2006 Jun; 17(6):509-16. PubMed ID: 16691348
[TBL] [Abstract][Full Text] [Related]
20. Preparation of micro-fabricated biodegradable polymeric structures using NCDS.
Lee JH; Ha WS; Chu WS; Park CW; Ahn SH; Chi SC
Arch Pharm Res; 2008 Jan; 31(1):125-32. PubMed ID: 18277618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
